Cargando…
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
SIMPLE SUMMARY: Positron emission tomography/computed tomography (PET/CT) with prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals is a relatively novel technique currently employed in the management of prostate cancer patients. These radiopharmaceuticals target PSMA, also known...
Autores principales: | Rizzo, Alessio, Racca, Manuela, Dall’Armellina, Sara, Rescigno, Pasquale, Banna, Giuseppe Luigi, Albano, Domenico, Dondi, Francesco, Bertagna, Francesco, Annunziata, Salvatore, Treglia, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857064/ https://www.ncbi.nlm.nih.gov/pubmed/36672305 http://dx.doi.org/10.3390/cancers15020355 |
Ejemplares similares
-
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023) -
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
por: Rizzo, Alessio, et al.
Publicado: (2022) -
Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
por: Dondi, Francesco, et al.
Publicado: (2022) -
Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis
por: Muoio, Barbara, et al.
Publicado: (2022) -
Bone Scintigraphy versus PSMA-Targeted PET/CT or PET/MRI in Prostate Cancer: Lessons Learned from Recent Systematic Reviews and Meta-Analyses
por: Dondi, Francesco, et al.
Publicado: (2022)